Xiaoying Gu

98.7k total citations · 2 hit papers
48 papers, 19.2k citations indexed

About

Xiaoying Gu is a scholar working on Infectious Diseases, Epidemiology and Molecular Biology. According to data from OpenAlex, Xiaoying Gu has authored 48 papers receiving a total of 19.2k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Infectious Diseases, 15 papers in Epidemiology and 9 papers in Molecular Biology. Recurrent topics in Xiaoying Gu's work include COVID-19 Clinical Research Studies (12 papers), Long-Term Effects of COVID-19 (9 papers) and Intensive Care Unit Cognitive Disorders (6 papers). Xiaoying Gu is often cited by papers focused on COVID-19 Clinical Research Studies (12 papers), Long-Term Effects of COVID-19 (9 papers) and Intensive Care Unit Cognitive Disorders (6 papers). Xiaoying Gu collaborates with scholars based in China, United States and United Kingdom. Xiaoying Gu's co-authors include Bin Cao, Yeming Wang, Guohui Fan, Jiuyang Xu, Fei Zhou, Zhibo Liu, Yi Zhang, Ronghui Du, Xudong Wu and Ting Yu and has published in prestigious journals such as The Lancet, Clinical Infectious Diseases and Stroke.

In The Last Decade

Xiaoying Gu

42 papers receiving 18.7k citations

Hit Papers

Clinical course and risk factors for mortality of adult i... 2020 2026 2022 2024 2020 2022 5.0k 10.0k 15.0k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study
    2020 18.1k citations Fei Zhou, Guohui Fan et al. profile →
  2. Health outcomes in people 2 years after surviving hospitalisation with COVID-19: a longitudinal cohort study
    2022 354 citations Lixue Huang, Xia Li et al. The Lancet Respiratory Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaoying Gu China 17 13.0k 6.8k 3.7k 2.3k 1.8k 48 19.2k
Jiuyang Xu China 13 13.4k 1.0× 6.7k 1.0× 3.8k 1.0× 2.3k 1.0× 1.8k 1.0× 28 19.3k
Guohui Fan China 16 12.9k 1.0× 6.4k 0.9× 3.8k 1.0× 2.4k 1.0× 1.8k 1.0× 61 18.9k
Yeming Wang China 20 13.1k 1.0× 6.8k 1.0× 3.8k 1.0× 2.5k 1.1× 1.8k 1.0× 66 19.5k
Xudong Wu China 27 12.7k 1.0× 6.4k 0.9× 4.0k 1.1× 2.2k 1.0× 1.8k 1.0× 86 21.1k
Shengjin Tu China 5 12.6k 1.0× 6.3k 0.9× 3.7k 1.0× 2.1k 0.9× 1.7k 0.9× 8 18.2k
Yuan Wei China 28 12.8k 1.0× 6.4k 0.9× 3.7k 1.0× 2.4k 1.1× 1.9k 1.0× 246 21.4k
Jie Xiang China 22 12.8k 1.0× 6.5k 1.0× 3.9k 1.0× 2.2k 1.0× 2.0k 1.1× 125 19.9k
Ronghui Du China 12 14.0k 1.1× 6.7k 1.0× 4.0k 1.1× 2.2k 1.0× 1.9k 1.1× 21 20.0k
Hua Chen China 22 12.7k 1.0× 6.4k 0.9× 3.9k 1.0× 2.1k 0.9× 1.7k 0.9× 68 19.5k

Countries citing papers authored by Xiaoying Gu

Since Specialization
Citations

This map shows the geographic impact of Xiaoying Gu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoying Gu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoying Gu more than expected).

Fields of papers citing papers by Xiaoying Gu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaoying Gu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoying Gu. The network helps show where Xiaoying Gu may publish in the future.

Co-authorship network of co-authors of Xiaoying Gu

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaoying Gu. A scholar is included among the top collaborators of Xiaoying Gu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaoying Gu. Xiaoying Gu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Zhang, Rongling, Xiaoying Gu, Hui Zhang, Yuming Guo, & Bin Cao. (2025). Long COVID: current research and future directions. 5(4). 260–271.
3.
Wu, Wanying, Wenjing Tang, Qin Li, et al.. (2025). GDF15 suppresses abdominal aortic aneurysm by upregulating AREG expression to adjust macrophage polarization. International Immunopharmacology. 159. 114899–114899.
4.
Huang, Lixue, Xiaoying Gu, Yuanqi Wang, et al.. (2024). Performance of various pneumonia severity models for predicting adverse outcomes in elderly inpatients with community-acquired pneumonia. Clinical Microbiology and Infection. 30(11). 1426–1432. 8 indexed citations
5.
Sun, Shuo, et al.. (2024). CdSe/ZnS Quantum Dot Patterned Arrays for Full-Color Light-Emitting Diodes in Active-Matrix QLED Display. ACS Applied Nano Materials. 7(8). 9086–9094. 6 indexed citations
6.
Gu, Xiaoying, et al.. (2024). Photonic Spin Hall Effect of Nanoparticles: Fundamentals, Advances, and Applications. Annalen der Physik. 537(4).
7.
Gu, Xiaoying, Siyuan Wang, Wanying Zhang, et al.. (2023). Probing long COVID through a proteomic lens: a comprehensive two-year longitudinal cohort study of hospitalised survivors. EBioMedicine. 98. 104851–104851. 31 indexed citations
8.
Fan, Guohui, Yuchang Zhou, Fei Zhou, et al.. (2023). The mortality and years of life lost for community-acquired pneumonia before and during COVID-19 pandemic in China. The Lancet Regional Health - Western Pacific. 42. 100968–100968. 7 indexed citations
9.
Yu, Miao, Wenjing Tang, Wei Liang, et al.. (2023). PCSK9 inhibition ameliorates experimental autoimmune myocarditis by reducing Th17 cell differentiation through LDLR/STAT-3/ROR-γt pathway. International Immunopharmacology. 124(Pt B). 110962–110962. 6 indexed citations
10.
11.
Huang, Lixue, Xia Li, Xiaoying Gu, et al.. (2022). Health outcomes in people 2 years after surviving hospitalisation with COVID-19: a longitudinal cohort study. The Lancet Respiratory Medicine. 10(9). 863–876. 354 indexed citations breakdown →
12.
Xu, Xia, Ke Huang, Fen Dong, et al.. (2021). The Heterogeneity of Inflammatory Response and Emphysema in Chronic Obstructive Pulmonary Disease. Frontiers in Physiology. 12. 783396–783396. 10 indexed citations
13.
Huang, Lixue, et al.. (2021). Procalcitonin-guided initiation of antibiotics in AECOPD inpatients: study protocol for a multicenter randomised controlled trial. BMJ Open. 11(8). e049515–e049515. 3 indexed citations
14.
Gu, Xiaoying, Changwei Li, Jiang He, et al.. (2020). Serum metabolites associate with lipid phenotypes among Bogalusa Heart Study participants. Nutrition Metabolism and Cardiovascular Diseases. 30(5). 777–787. 7 indexed citations
15.
16.
Xu, Jiuyang, Chaolin Huang, Guohui Fan, et al.. (2020). Use of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in context of COVID-19 outbreak: a retrospective analysis. Frontiers of Medicine. 14(5). 601–612. 32 indexed citations
17.
Liu, Zhibo, Guohui Fan, Fei Zhou, et al.. (2020). Low-to-moderate dose corticosteroids treatment in hospitalized adults with COVID-19. Clinical Microbiology and Infection. 27(1). 112–117. 30 indexed citations
18.
Fang, Fang, Ke Huang, Fen Dong, et al.. (2020). <p>Enjoying Breathing Program: A National Prospective Study Protocol to Improve Chronic Obstructive Pulmonary Disease Management in Chinese Primary Health Care</p>. International Journal of COPD. Volume 15. 2179–2187. 9 indexed citations
19.
Li, Changwei, Jiang He, Shengxu Li, et al.. (2019). Novel Metabolites Are Associated With Augmentation Index and Pulse Wave Velocity: Findings From the Bogalusa Heart Study. American Journal of Hypertension. 32(6). 547–556. 19 indexed citations
20.
Gu, Xiaoying, Xueli Yang, Ying Li, et al.. (2015). Usefulness of Low-Density Lipoprotein Cholesterol and Non–High-Density Lipoprotein Cholesterol as Predictors of Cardiovascular Disease in Chinese. The American Journal of Cardiology. 116(7). 1063–1070. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jiuyang Xu Breakdown of academic impact, for papers by Guohui Fan Breakdown of academic impact, for papers by Yeming Wang Breakdown of academic impact, for papers by Xudong Wu Breakdown of academic impact, for papers by Shengjin Tu Breakdown of academic impact, for papers by Yuan Wei Breakdown of academic impact, for papers by Jie Xiang Breakdown of academic impact, for papers by Ronghui Du Breakdown of academic impact, for papers by Hua Chen
Rankless by CCL
2026